BG60324B2 - New somatotropines - Google Patents

New somatotropines

Info

Publication number
BG60324B2
BG60324B2 BG92028A BG9202890A BG60324B2 BG 60324 B2 BG60324 B2 BG 60324B2 BG 92028 A BG92028 A BG 92028A BG 9202890 A BG9202890 A BG 9202890A BG 60324 B2 BG60324 B2 BG 60324B2
Authority
BG
Bulgaria
Prior art keywords
somatotropines
new
somatotropins
somatotropin
asparagine
Prior art date
Application number
BG92028A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gwen Krivi
Michael Schlittler
Bernard Violand
Original Assignee
Monsanto Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Company filed Critical Monsanto Company
Publication of BG60324B2 publication Critical patent/BG60324B2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BG92028A 1988-08-29 1990-05-16 New somatotropines BG60324B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/237,358 US5089473A (en) 1988-08-29 1988-08-29 Somatotropin variants and their use
PCT/US1989/003641 WO1990002182A1 (en) 1988-08-29 1989-08-28 Novel somatotropins

Publications (1)

Publication Number Publication Date
BG60324B2 true BG60324B2 (en) 1994-07-25

Family

ID=22893393

Family Applications (1)

Application Number Title Priority Date Filing Date
BG92028A BG60324B2 (en) 1988-08-29 1990-05-16 New somatotropines

Country Status (14)

Country Link
US (1) US5089473A (es)
EP (2) EP0403601B1 (es)
JP (1) JP2784232B2 (es)
AU (1) AU614879B2 (es)
BG (1) BG60324B2 (es)
BR (1) BR8907068A (es)
CA (1) CA1340122C (es)
DE (1) DE68906261T2 (es)
ES (2) ES2016069A4 (es)
HU (1) HUT54409A (es)
IL (1) IL91457A (es)
NZ (1) NZ230458A (es)
WO (1) WO1990002182A1 (es)
ZA (1) ZA896557B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631227A (en) * 1985-09-18 1997-05-20 The Upjohn Company Somatotropin analogs
US5130422A (en) * 1988-08-29 1992-07-14 Monsanto Company Variant somatotropin-encoding DNA
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9823071D0 (en) * 1998-10-21 1998-12-16 Affibody Technology Ab A method
US6238706B1 (en) 1999-05-06 2001-05-29 Grofish L.L.C. Method of stimulating growth in aquatic animals using growth hormones
US7611700B2 (en) * 2002-09-09 2009-11-03 Hanall Pharmaceuticals, Co., Ltd. Protease resistant modified interferon alpha polypeptides
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG162687A1 (en) 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
US8680050B2 (en) * 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (es) 1982-12-22 1984-10-02 Genentech Inc
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
ES8800957A1 (es) 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
EP0263206B1 (en) * 1986-10-08 1990-12-12 The Upjohn Company Enhanced bioactivity of mammalian somatotropin through selective deamidation
ATE57937T1 (de) * 1985-09-18 1990-11-15 Upjohn Co Erhoehte biowirkung von saeugetier-somatotropin durch selektive deamidierung.
IL82017A (en) 1986-03-27 1996-01-19 Monsanto Co Increased production of protein in bacteria by using a ribosomal linker site based on bacteriophage T7 gene 01
DE68929273T2 (de) * 1988-08-24 2001-07-05 American Cyanamid Co Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung

Also Published As

Publication number Publication date
IL91457A0 (en) 1990-04-29
JP2784232B2 (ja) 1998-08-06
DE68906261D1 (de) 1993-06-03
WO1990002182A1 (en) 1990-03-08
IL91457A (en) 1994-04-12
JPH03501856A (ja) 1991-04-25
EP0403601B1 (en) 1993-04-28
EP0403601A1 (en) 1990-12-27
ES2016069A4 (es) 1990-10-16
AU4316089A (en) 1990-03-23
US5089473A (en) 1992-02-18
HUT54409A (en) 1991-02-28
AU614879B2 (en) 1991-09-12
NZ230458A (en) 1991-11-26
ES2054096T3 (es) 1994-08-01
EP0363342A1 (en) 1990-04-11
BR8907068A (pt) 1990-10-02
CA1340122C (en) 1998-11-10
DE68906261T2 (de) 1993-11-11
ZA896557B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
BG60324B2 (en) New somatotropines
FR2573310B1 (fr) Ampoule pour seringue hypodermique, en particulier seringue auto-injectante
NO880719L (no) Polypeptid, dna og anvendelse derav.
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
IT8753157V0 (it) Siringa dentaria per iniezioni intralegamentarie
NO175158C (no) Fremstilling av human livmorsvevplasminogenaktivator med rekombinant-DNA
KR890700359A (ko) 안정한 인터페론 복합체
DK357386D0 (da) Saarhelende midler
NO2002009I2 (no) Tiotropium
EP0190018A3 (en) Use of transforming growth factor to promote wound healing and composition therefor
DE3770830D1 (de) Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
KR910018038A (ko) 원발성 흉막암의 치료를 위한 제약 조성물 제조용 인체 인터루킨 2활성 함유 폴리펩티드의 용도
KR950702432A (ko) 라이소자임 이량체와 이를 포함하는 조성물(Lysozyme dimer and compositions containing the same)
KR880700820A (ko) 맥관인자(paf)
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
ATE59550T1 (de) Chlorpheniramine therapie.
ES2061496T3 (es) Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante.
FI920428A0 (fi) Ett podofyllotoxinpreparat som innehaoller triglyserider.
DE69018357D1 (de) Mutein von HST-1 und seine Herstellung.
ES2104551T3 (es) Analogos terapeuticos de somatostatina.
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
ES279057U (es) Jeringuilla para inyecciones
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
IT8819559A0 (it) Impiego terapeutico dell'acido uridinfosfoglucuronico (udpg_a)come attivatore della glucuronconiugazione del trattamento di epatopie ed itteri.